Want to see TSE:CL full AI Analyst Report?
Cresco Labs (CL) Stock Price & Analysis
CL Stock Chart & Stats
- Day’s Range
- CAD 0.81 - CAD 0.92
- 52-Week Range
- CAD 0.79 - CAD 3.12
- Previous Close
- CAD 0.88
- Volume
- N/A
- Average Volume (3M)
- 79.50K
- Market Cap
- CAD 379.02M
- Enterprise Value
- CAD 1.17B
- Total Cash (Recent Filing)
- CAD 32.87M
- Total Debt (Recent Filing)
- CAD 592.02M
- Price to Earnings (P/E)
- ―
- Beta
- 2.20
- Next Earnings
- Nov 06, 2026 (Est.)
- EPS Estimate
- -0.02
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Operating Improvement
Positive EBIT and EBITDA, together with a roughly 48% gross margin, show that Cresco’s core operations have improved beyond its historical loss profile. If maintained, this operating progress can support reinvestment, stronger cost absorption, and eventual bottom-line recovery.
Positive Operating Cash Flow
Positive operating cash flow indicates that the business is generating cash from its operations despite reported net losses. This provides some internal funding capacity and is a constructive foundation, although the limited coverage of net loss means cash generation is not yet sufficiently strong.
Integrated Market Model
Cresco operates across cultivation, manufacturing, wholesale distribution, and owned retail, giving it multiple routes to reach regulated-market customers. This integrated model can improve control over product development, shelf access, and customer relationships across state markets.
Bears Say
Persistent Net Losses
The meaningful net loss shows that operating improvement has not yet translated into sustainable bottom-line profitability. Continued losses can constrain reinvestment, weaken financial resilience, and make the company more dependent on operating improvement before growth can compound.
Elevated Leverage
High leverage relative to the equity base reduces balance-sheet flexibility while negative ROE indicates that invested capital is not yet producing profitable returns. This combination can limit strategic options and increase the importance of consistent earnings improvement.
Unstable Revenue Trend
The uneven revenue pattern indicates that recent recovery has not yet established a consistent growth trajectory. Choppy sales make it harder to plan capacity, absorb fixed costs, and demonstrate that improved operating performance can persist across future reporting periods.
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
What is Cresco Labs’s market cap?
When is Cresco Labs’s upcoming earnings report date?
How were Cresco Labs’s earnings last quarter?
Is Cresco Labs overvalued?
Does Cresco Labs pay dividends?
What is Cresco Labs’s EPS estimate?
How many shares outstanding does Cresco Labs have?
What happened to Cresco Labs’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Cresco Labs?
What is the TipRanks Smart Score and how is it calculated?
Cresco Labs Stock Smart Score
Company Description
Cresco Labs
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Charles Bachtell
- Employees
- 2,900
- Website
- www.crescolabs.com
- Address
- 600 W. Fulton Street, Chicago, IL, 60661, US
Cresco Labs (CL) Earnings & Revenues
CL Company Deck
CL Earnings Call
Earnings Call SentimentPositive
The call presents a cautiously optimistic outlook: management delivered solid Q1 margins and EBITDA from a streamlined cost structure, achieved meaningful operational and licensing wins (PA store expansion, Ohio openings, Kentucky harvest, Texas license) and provided constructive Q2 growth guidance (~+10% revenue). Offsets include near-term revenue headwinds from the planned California exit and Michigan excise tax, ongoing pricing compression, seasonal cash flow timing, and unresolved regulatory details around rescheduling (including the scope and timing of 280E relief). On balance, operational momentum, accretive M&A activity, and licensing progress outweigh the short-term market and regulatory challenges.
View all TSE:CL earnings summariesCL Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 6 | 14 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 0 | 0 | 12 |
